Europe Glass Packaging Market Share to Explore at 4.5% CAGR to 2024Europe Bioreactors Market Size to Dominate Over USD 850 Mn by 2025 - PowerPoint PPT Presentation

About This Presentation

Europe Glass Packaging Market Share to Explore at 4.5% CAGR to 2024Europe Bioreactors Market Size to Dominate Over USD 850 Mn by 2025


Graphical Research has reported the addition of the “Bioreactors Market: Europe Industry Analysis and Opportunity Assessment 2019 - 2025" report to their offering. – PowerPoint PPT presentation

Number of Views:83


Transcript and Presenter's Notes

Title: Europe Glass Packaging Market Share to Explore at 4.5% CAGR to 2024Europe Bioreactors Market Size to Dominate Over USD 850 Mn by 2025


Europe Bioreactors Market Size to Widen at 17.1
CAGR During 2019-2025 Graphical Research
2018 Graphical Research. All rights

Europe bioreactors industry is largely driven by
technological advancements related to bioreactor
material, design and processing. Various
technological innovation such as continuous
manufacturing, process analytical technology, and
single-use systems in bioreactors contribute to
advancements in biological processes. Hence, the
above-mentioned reasons will augment bioreactors
market growth over the forecast timeframe.
According to the Graphical Research new growth
forecast report titled Europe Bioreactors
Market By Technology (Wave-induced Motion SUB,
Stirred SUB, Single Use Bubble Column), By
Molecule (Monoclonal Antibodies, Vaccines,
Recombinant Proteins, Stem Cells, Gene
Therapy)  By End-use (RD Organizations,
Biopharma Manufacturers, CMOs), By Cell
(Mammalian Cells, Bacterial Cells, Yeast Cells),
Industry Analysis Report, Country Outlook
(Germany, UK, Spain, Italy, France, The
Netherlands, Denmark, Russia, Poland, Sweden,
Norway) Estimated to collect USD 850 million by
2025. Request for a sample of this report
_at_ https//
ample The bioreactors market is expected to
witness considerable growth across the forecast
timeframe owing to rising biopharmaceutical
industry. The growth of biopharmaceutical
industry can be attributed to increased
investment in technological developments,
especially in the targeted and personalized
therapies, rising prevalence of chronic diseases,
and growing geriatric population. Moreover,
orphan drugs offer an integrated healthcare
solution that enables biopharma industry to
develop new areas of patient support,
therapeutics, treatment, diagnosis, and
monitoring. The number of FDA designations of
orphan drugs has increased steadily over the past
decade, thus augmenting bioreactors market
2018 Graphical Research. All rights
  • However, vulnerability to leaching, regulatory
    concerns regarding single-use bioreactor and
    limited storage capacity should hinder bioreactor
    market growth. Additionally, large-scale disposal
    of plastic derivatives is a growing environmental
    concern restraining the business growth over the
    forecast years.
  • Europe Bioreactors Market research report
    includes in-depth coverage of the industry with
    estimates forecast in terms of revenue in USD
    million from 2014 to 2025, for the following
  • Europe Bioreactors Market Share, By Cell,
    2014-2025, (USD Million)
  • Mammalian cells
  • Bacterial cells
  • Yeast cells
  • Others
  • Europe Bioreactors Market Size, By Molecule,
    2014-2025, (USD Million)
  • Monoclonal antibodies
  • Vaccines
  • Recombinant protein
  • Stem cell
  • Gene therapy
  • Others

2018 Graphical Research. All rights
  • Europe Bioreactors Market Value, By Technology,
    2014-2025, (USD Million)
  • Wave-induced motion SUB
  • Stirred SUB
  • Stirred-use bubble column
  • Others
  • Europe Bioreactors Market Trends, By End-use,
    2014-2025, (USD Million)
  • Research and development (RD) organizations
  • Biopharma manufacturers
  • Contract manufacturing organizations (CMOs)
  • Bacterial cells segment is estimated to expand at
    16.9 CAGR over the forecast timeframe. Bacterial
    cells are robust and not prone to damage. It
    provides bioreactors with the high mass transfer
    competence, permit rapid metabolism, and supports
    high-cell density microbial cell cultivation and
    growth in the quantity of product. Recombinant
    proteins can also be produced through bacterial
    cells. Hence, the above-mentioned factors will
    propel bacterial cells segmental growth.
  • Recombinant protein segment generated over USD
    34.9 million in 2018. High growth is attributed
    to growing applications of recombinant proteins
    in the treatment of several diseases, including
    rheumatic conditions, and different types of
    cancer. The recombinant protein segment has grown
    at a significant rate, demonstrating an
    economically robust future for the bioreactors

2018 Graphical Research. All rights

Stirred SUBs segment is expected to witness
substantial growth rate of 17.1 across the
forecast timeframe, owing to extensive use in
modern biotechnological processes. The stirred
SUBs are widely used for mammalian cell cultures
such as production of monoclonal antibodies
(mAbs), and vaccines. They have several
advantages such as short turnaround times and
reduced risk of cross contaminations. Hence, the
aforementioned reasons will positively drive
segmental growth. Browse key industry insights
along with Table of Content _at_ https//www.graphica
ctors-market Biopharma manufacturers segment was
valued at USD 88.9 million in 2018 and is
projected to witness strong growth over the
forecast years. High growth is attributed to
increase in the number of biopharmaceutical
products in pipeline including with growing
establishment of new facilities to meet the
production needs. Furthermore, large
biopharmaceutical companies and biosimilar
producers are entering strategic collaborations
with new entrants to facilitate business
expansion. Germany is estimated to hold major
chunk of revenue share of 25.9 in 2018 and is
anticipated to grow at a significant growth rate
in the coming years. Increasing number of
biopharmaceutical companies responsible for
bringing new medicines to patients and their
collaborations with venture capital firms,
academic institutions, and patients will
accelerate the Europe bioreactors market during
the forecast period. 
2018 Graphical Research. All rights

Major market players in Europe bioreactors market
are Applikon Biotechnology, Inc., Bbi-biotech,
Cellexus Limited, CerCell Aps, Eppendorf AG, GE
Healthcare, GEA Group Aktiengesellschaft, Merck
Group, Pierre Guerin Sas, Sartorius Stedim
Biotech Group, Solaris Biotech Solutions and
Thermo Fisher Scientific Inc. These market
players are undertaking strategies such as
technology development and acquisitions to gain
market presence and for company
expansion. Related Reports Asia Pacific
Bioreactors Market  https//
North America Bioreactors Market
2018 Graphical Research. All rights

About Graphical Research Graphical Research is
a business research firm that provides industry
insights, market forecast and strategic inputs
through granular research reports and advisory
services. We publish targeted research reports
with an aim to address varied customer needs,
from market penetration and entry strategies to
portfolio management and strategic outlook. We
understand that business requirements are unique
our syndicate reports are designed to ensure
relevance for industry participants across the
value chain. We also provide custom reports that
are tailored to the exact needs of the customer,
with dedicated analyst support across the
purchase lifecycle. Contact Us Parikhit
B. Corporate sales, Graphical
Research Email Web
2018 Graphical Research. All rights

Stay In Touch With Us For
Website Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
Write a Comment
User Comments (0)